Needham analyst Alex Henderson maintains Silicom (NASDAQ:SILC) with a Buy and lowers the price target from $65 to $58.
Why Is Pain Treatment Focused Heron Therapeutics Stock Trading Higher Today?
Heron Therapeutics Inc (NASDAQ: HRTX) reported Q3 sales of $31.43 million, missing the consensus of $32.75 million.